Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis:: Safety and efficacy in an open-label clinical trial

被引：0
|
作者：
Antoni, CE
Nüsslein, HG
Wollenhaupt, J
Burmester, GR
Krüger, K
Kalden, JR
机构：
[1] Univ Erlangen Nurnberg, Med Klin & Poliklin 3, D-8520 Erlangen, Germany
[2] Stadt Klinikum Dresden, Med Klin Friedrichstadt 1, Dresden, Germany
[3] Allgemeines Krankenhaus Eilbek, Abt Rheumatol & Klin Immunol, Hamburg, Germany
[4] Univ Berlin, Charite, Med Klin Rheumatol, Berlin, Germany
[5] Rheumazentrum, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [21] Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis
    Lee, S-S.
    Park, Y-W.
    Park, J. J.
    Kang, Y. M.
    Nam, E. J.
    Kim, S. I.
    Lee, J. H.
    Yoo, W-H.
    Lee, S-I.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (01) : 11 - 14
  • [22] Clinical aspects of infliximab and leflunomide combination therapy in rheumatoid arthritis
    Sidenco, Elena-Luminita
    Tugui, R.
    Chijan, D.
    Mitache, E.
    INFLAMMATION RESEARCH, 2007, 56 : S449 - S449
  • [23] Safety and efficacy of the combination of leflunomide and etanercept in rheumatoid arthritis
    Fiocco, U.
    Vezzu, M.
    Sfriso, P.
    Cozzi, L.
    Checchetto, C.
    Ciprian, L.
    Botsios, C.
    Todesco, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 190 - 191
  • [24] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun-Bong
    Genovese, Mark
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
  • [25] EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSIONOF A PHASE III MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Burrnester, Gerd R.
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jon
    Lee, Eun Bong
    Genovese, Mark C.
    RHEUMATOLOGY, 2018, 57
  • [26] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd R.
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun Bong
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] COMPARISON OF RITUXIMAB VERSUS LEFLUNOMIDE IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE TREATMENT- AN OPEN LABEL, RANDOMISED CONTROLLED TRIAL
    Roongta, R.
    Sircar, G.
    Ghosh, P.
    Sit, H.
    Ghosh, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1328 - 1329
  • [28] Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 554 - 562
  • [29] Safety and efficacy of the association of leflunomide-infliximab versus methotrexate-infliximab in patients with rheumatoid arthritis
    Ibañez, TC
    Tayel, MY
    Sanz, AH
    Criado, AB
    Martín-Mola, E
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 469 - 469
  • [30] EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSION OF A PHASE 3 MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)
    Burmester, G. R.
    Fiore, S.
    Hu, C-C
    van Hoogstraten, H.
    Lee, Bong E.
    Genovese, M. C.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 21 - 21
12345